石药银湖制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
113
NMPA:113
Drug Approvals
Levofloxacin and Sodium Chloride Injection
- Product Name
- 左氧氟沙星氯化钠注射液
- Approval Number
- 国药准字H20249701
- Approval Date
- Dec 6, 2024
NMPA
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20247067
- Approval Date
- Apr 15, 2024
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20193099
- Approval Date
- Apr 8, 2024
NMPA
Sodium Acetate Ringer's Injection
- Product Name
- 醋酸钠林格注射液
- Approval Number
- 国药准字H20247060
- Approval Date
- Apr 1, 2024
NMPA
Sodium Acetate Ringer's Injection
- Product Name
- 醋酸钠林格注射液
- Approval Number
- 国药准字H20183266
- Approval Date
- Jun 26, 2023
NMPA
Levofloxacin Hydrochloride Injection
- Product Name
- 盐酸左氧氟沙星注射液
- Approval Number
- 国药准字H20084164
- Approval Date
- May 25, 2023
NMPA
Sterile Water for Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H20084153
- Approval Date
- May 25, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found